P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

Lignende værker

• Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
  af: Sikander Ailawadhi, et al.
  Udgivet: (2024-11-01)
• Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
  af: Hans C. Lee, et al.
  Udgivet: (2021-07-01)
• Connect MM Registry as a national reference for United States multiple myeloma patients
  af: Sikander Ailawadhi, et al.
  Udgivet: (2020-01-01)
• Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
  af: Sundar Jagannath, et al.
  Udgivet: (2018-07-01)
• Lenalidomide-Associated ITP
  af: Christina I. Herold, et al.
  Udgivet: (2011-01-01)